Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
225.67
+0.74 (0.33%)
May 27, 2025, 3:53 PM - Market open
Humana Stock Forecast
Stock Price Forecast
According to 20 professional analysts, the 12-month price target for Humana stock ranges from a low of $250 to a high of $326. The average analyst price target of $285.4 forecasts a 26.47% increase in the stock price over the next year.
Price Target: $285.40 (+26.47%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Humana stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Hold | 17 | 17 | 17 | 17 | 15 | 15 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 24 | 23 | 23 | 22 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $325 → $305 | Hold | Maintains | $325 → $305 | +35.15% | May 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $290 | Hold | Reiterates | $290 | +28.51% | May 1, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $300 → $310 | Buy | Maintains | $300 → $310 | +37.37% | May 1, 2025 |
| Baird | Baird | Hold Maintains $270 → $300 | Hold | Maintains | $270 → $300 | +32.94% | Apr 15, 2025 |
| Barclays | Barclays | Hold Maintains $270 → $322 | Hold | Maintains | $270 → $322 | +42.69% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
128.03B
from 117.76B
Increased by 8.72%
Revenue Next Year
131.72B
from 128.03B
Increased by 2.88%
EPS This Year
16.52
from 9.98
Increased by 65.56%
EPS Next Year
14.88
from 16.52
Decreased by -9.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 134.4B | 146.7B | 160.5B | ||
| Avg | 128.0B | 131.7B | 143.3B | ||
| Low | 122.4B | 118.6B | 123.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.2% | 14.6% | 21.9% | ||
| Avg | 8.7% | 2.9% | 8.8% | ||
| Low | 3.9% | -7.4% | -6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.83 | 19.30 | 25.26 | ||
| Avg | 16.52 | 14.88 | 21.99 | ||
| Low | 15.93 | 10.34 | 18.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 78.6% | 16.8% | 69.8% | ||
| Avg | 65.6% | -9.9% | 47.8% | ||
| Low | 59.6% | -37.4% | 25.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.